Trademark Overview
On Friday, February 6, 2026, a trademark application was filed for MEDIVIVE with the United States Patent and Trademark Office. The USPTO has given the MEDIVIVE trademark a serial number of 99638938. The federal status of this trademark filing is NEW APPLICATION - RECORD INITIALIZED NOT ASSIGNED TO EXAMINER as of Friday, February 6, 2026. This trademark is owned by Helivore Holdings Ltd.. The MEDIVIVE trademark is filed in the Pharmaceutical Products and Computer & Software Services & Scientific Services categories with the following description:
Providing temporary use of non-downloadable cloud-based software for healthcare professionals to order medical supplies, manage patient prescriptions, and process secure uploads of prescription documents; Software as a service (SAAS) services featuring software for physicians to place orders for injectable pharmaceuticals, upload and store electronic prescriptions, and track inventory of medical goods
Pharmaceutical preparations for regenerative and anti-aging purposes; Pharmaceutical preparations for medical use in cellular energy support, anti-aging therapy, and metabolic enhancement; pharmaceutical preparations containing nicotinamide adenine dinucleotide (NAD+) for use in anti-aging and metabolic-enhancement therapies; injectable pharmaceutical formulations containing nicotinamide adenine dinucleotide (NAD+) for medical use in cellular energy support, anti-aging therapy, and metabolic enhancement; auto-injector pens sold pre-filled with pharmaceutical preparations containing NAD+ for subcutaneous or intramuscular administration
